PubMed Health⌕ Search

Biomedical subjects

Ia M Ena

Publications and source records attributed to Ia M Ena.

At least 19 recordsLinked to original sources
PubMed1992

[The content of ceruloplasmin, fibronectin and selenium in the blood of patients with an acute myocardial infarct].

The content of ceruloplasmin, fibronectin and selenium was evaluated in the blood plasma of acute myocardial infarction patients within the first three days after onset if the disease. Results showed a reduction of fibronectin during the first hours after onset of the disease. The content of ceruloplasmin was increased, selenium reduced during the entire period of examination indicating pronounced disturbances of lipid peroxidation in the acute period of myocardial infarction as well as potentiation of antioxidant processes.

Adult↗
PubMed1991

[Clinical and hemostatic evaluation of curantyl in hypertensives].

Curantyl supplemented to the multimodality therapy for patients with Stage II essential hypertension with uncomplicated events or complicated by hypertensive crisis was ascertained to lower the intensity of intravascular blood microcoagulation due to its modifying effect on the procoagulative and thrombocytic links of hemostasis and blood fibrinolytic activity. The drug exerted no marked positive action on clinical manifestations of the disease and caused no significant changes in the parameters of hemostatic procoagulative and thrombocytic links and blood fibrinolytic activity.

Adult↗
PubMed1991

[Plasmapheresis combined with hemosorption in the treatment of hypertension patients].

It was established that use of plasmapheresis in association with hemosorption in 36 patients suffering of hypertensive disease improved the clinical course of the disease, reduced the resistance to drug treatment, increased the treatment efficacy, decreased the risk of complications. Simultaneously there was an improvement of the hemodynamics and hemorheological properties of the blood.

Adult↗
PubMed1990

[Fibrinolysis in patients with hypertension].

Clinical and hemostasis evidence on fibrinolysis is presented for patients with hypertension running an uneventful course, in hypertensive crisis and acute disorder of cerebral circulation. Changes in fibrinolysis are shown for patients on conventional treatment and on adjuvant dipyridamole.

Adult↗